Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 07 Feb 2025

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms

in Hematologic Malignancies

Esther Natalie Oliva
Shien Guo
Jennifer Lord-Bessen
Aylin Yucel
Roberto Latagliata
Massimo Breccia
Giuseppe A. Palumbo
Grazia Sanpaolo
Marta Riva
Valeria Santini

Frontiers in Oncology

doi 10.3389/fonc.2025.1507854

636 views

Case Report

Published on 04 Feb 2025

Unusual symptoms reveal a rare splenic lymphoma: a case report of PS-DLBCL with neck and shoulder pain as the initial presentation

in Hematologic Malignancies

Shifu Hu
Yuanyuan Hao
Xiangyu Liu
Hanbo Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1449966

728 views

Systematic Review

Published on 31 Jan 2025

Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis

in Hematologic Malignancies

Hongbin Lu
Lulu Luo
Jie Mi
Min Sun
Huaping Wang
Zheng Wang
Wenwen Ding

Frontiers in Oncology

doi 10.3389/fonc.2025.1506799

676 views

Case Report

Published on 30 Jan 2025

Daratumumab treatment for kidney-involved light chain deposition disease prevents renal function progression: a case report with 3 years of follow-up and review of the literature

in Hematologic Malignancies

Xueying Chen
Jie Sun
Pingyan Shen
Zijin Chen
Wen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1466323

757 views

Original Research

Published on 24 Jan 2025

Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients

in Hematologic Malignancies

MV Chandrakanth
Vivek Agarwala
Pranav Sopory
Himadri Nayak
Purvish M. Parikh
Minakshi Roy
Rajib De
Pradeep Narayan
Anjuli Tuladhar Barai
Kaustav Mandal

Frontiers in Oncology

doi 10.3389/fonc.2025.1418327

1,050 views
1 citation

Review

Published on 21 Jan 2025

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies

in Hematologic Malignancies

Mariam Markouli
Maria N. Pagoni
Panagiotis Diamantopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1501950

1,662 views

Case Report

Published on 21 Jan 2025

Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review

in Hematologic Malignancies

Hongxia Wang
Junjun Bai
Bei Zhang
Zhixin Pei
Yingxin Zhao
Jingjing Gu
Zhiyu Fang
Miaomiao Liu
Xun Liang
Qinglin Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1480880

769 views

Systematic Review

Published on 21 Jan 2025

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia

in Hematologic Malignancies

P. Joy Ho
Hang Quach
M. Hasib Sidiqi
Cindy H. Lee
Jason Butler
Andrew Spencer
Kenneth Micklethwaite
Jingya Li
Elissa Cusson
Robert Bagnall

Frontiers in Oncology

doi 10.3389/fonc.2024.1535869

1,962 views

Original Research

Published on 21 Jan 2025

Transcription factor KLF2 is associated with the dysfunctional status of NK cells and the prognosis of pediatric B-ALL patients

in Hematologic Malignancies

Fang Wu
Huimin Xu
Benshan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1456004

894 views

Review

Published on 20 Jan 2025

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia

in Hematologic Malignancies

Elissa Tjahjono
Megan R. Daneman
Bernadetta Meika
Alexey V. Revtovich
Natalia V. Kirienko

Frontiers in Oncology

doi 10.3389/fonc.2024.1532857

1,691 views

Review

Published on 16 Jan 2025

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma

in Hematologic Malignancies

Hong Yan
Nan Jiang
Xiaoying Li
Chenyang Lin
Fang Wang
Juan Zhang
Lijuan Chen
Dan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1522491

1,020 views
1 citation

Original Research

Published on 07 Jan 2025

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study

in Hematologic Malignancies

Zhiqiang Zhao
Qinchuan Yu
Liping Su
Jianxia He
Jie Tao
Yanfeng Xi
Yujiao Guo
Yanhong Luo
Lieyang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1494384

846 views

Original Research

Published on 07 Jan 2025

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML

in Hematologic Malignancies

Petra Bašová
Lubomír Minařík
Silvia Carina Magalhaes-Novais
Jana Balounová
Zuzana Zemanová
Tatiana Aghová
Martin Špaček
Anna Jonášová
Kristýna Gloc Pimková
Jan Procházka

Frontiers in Oncology

doi 10.3389/fonc.2024.1414950

1,316 views

Systematic Review

Published on 07 Jan 2025

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis

in Hematologic Malignancies

Jile Liu
Yuxin An
Rui Sun
Xiaomei Zhang
Shujing Guo
Xuejin Gao
Mingfeng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1478888

1,344 views

Original Research

Published on 06 Jan 2025

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes

in Hematologic Malignancies

Lisa Dietsche
Kristin Stirm
Veronika Lysenko
Corina Schneidawind
Alexandar Tzankov
Anne Müller
Alexandre P. A. Theocharides

Frontiers in Oncology

doi 10.3389/fonc.2024.1481713

928 views

Editorial

Published on 06 Jan 2025

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II

in Hematologic Malignancies

Lokman Varisli
Garrett M. Dancik
John A. Copland
Spiros A. Vlahopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1542306

510 views